메뉴 건너뛰기




Volumn 49, Issue 3, 2008, Pages 272-275

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study

Author keywords

Hepatitis A vaccine; HIV 1; Immune responses; Randomized trial; Vaccination

Indexed keywords

ANTIBODY; HEPATITIS A VACCINE; HEPATITIS A ANTIBODY;

EID: 58149160364     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318183a9c0     Document Type: Article
Times cited : (58)

References (16)
  • 1
    • 0032576759 scopus 로고    scopus 로고
    • Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
    • Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286-290.
    • (1998) N Engl J Med , vol.338 , pp. 286-290
    • Vento, S.1    Garofano, T.2    Renzini, C.3
  • 2
    • 0038053180 scopus 로고    scopus 로고
    • Who should receive hepatitis A vaccine?
    • Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? J Viral Hepat. 2003;10:157-158.
    • (2003) J Viral Hepat , vol.10 , pp. 157-158
    • Arankalle, V.A.1    Chadha, M.S.2
  • 3
    • 34147151237 scopus 로고    scopus 로고
    • Immunization of the HIV infected traveller
    • Chadwick DR, Geretti AM. Immunization of the HIV infected traveller. AIDS. 2007;21:787-794.
    • (2007) AIDS , vol.21 , pp. 787-794
    • Chadwick, D.R.1    Geretti, A.M.2
  • 4
    • 0030894881 scopus 로고    scopus 로고
    • The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-I infection: 1-year follow-up
    • Bodsworth NJ, Neilsen GA, Donovan B. The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-I infection: 1-year follow-up. AIDS. 1997;11:747-749.
    • (1997) AIDS , vol.11 , pp. 747-749
    • Bodsworth, N.J.1    Neilsen, G.A.2    Donovan, B.3
  • 5
    • 0345269168 scopus 로고    scopus 로고
    • Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: A double-blind, randomized, placebo-controlled trial
    • Kemper CA, Haubrich R, Frank I, et al. Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. J Infect Dis. 2003; 187:1327-1331.
    • (2003) J Infect Dis , vol.187 , pp. 1327-1331
    • Kemper, C.A.1    Haubrich, R.2    Frank, I.3
  • 6
    • 27144551779 scopus 로고    scopus 로고
    • Response to hepatitis A vaccine in HIV patients in the HAART era
    • Rimland D, Guest JL. Response to hepatitis A vaccine in HIV patients in the HAART era. AIDS. 2005;19:1702-1704.
    • (2005) AIDS , vol.19 , pp. 1702-1704
    • Rimland, D.1    Guest, J.L.2
  • 7
    • 33846967799 scopus 로고    scopus 로고
    • Predictors of immunity after hepatitis A vaccination in HIV-infected persons
    • Overton ET, Nurutdinova D, Sungkanuparph S, et al. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J Viral Hepat. 2007;14:189-193.
    • (2007) J Viral Hepat , vol.14 , pp. 189-193
    • Overton, E.T.1    Nurutdinova, D.2    Sungkanuparph, S.3
  • 8
    • 30944454860 scopus 로고    scopus 로고
    • Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy
    • Weinberg A, Gona P, Nachman SA, et al. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis. 2006;193:302-311.
    • (2006) J Infect Dis , vol.193 , pp. 302-311
    • Weinberg, A.1    Gona, P.2    Nachman, S.A.3
  • 9
    • 0028928908 scopus 로고
    • Clinical experience with an inactivated hepatitis Avaccine
    • Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis Avaccine. J Infect Dis. 1995;171(Suppl 1):S44-S49.
    • (1995) J Infect Dis , vol.171 , Issue.SUPPL. 1
    • Clemens, R.1    Safary, A.2    Hepburn, A.3
  • 10
    • 0027745966 scopus 로고
    • Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: Effects of single and booster injections, and comparison to administration of immune globulin
    • Shouval D, Ashur Y, Adler R, et al. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. J Hepatol. 1993;18(Suppl 2):S32-S37.
    • (1993) J Hepatol , vol.18 , Issue.SUPPL. 2
    • Shouval, D.1    Ashur, Y.2    Adler, R.3
  • 11
    • 0026483854 scopus 로고
    • Clinical assessment of the safety and efficacy of an inactivated hepatitis Avaccine: Rationale and summary of findings
    • Andre FE, D'Hondt E, Delem A, et al. Clinical assessment of the safety and efficacy of an inactivated hepatitis Avaccine: rationale and summary of findings. Vaccine. 1992;10(Suppl 1):S160-S168.
    • (1992) Vaccine , vol.10 , Issue.SUPPL. 1
    • Andre, F.E.1    D'Hondt, E.2    Delem, A.3
  • 12
    • 29044443174 scopus 로고    scopus 로고
    • Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: A hierarchical bayesian meta-analysis
    • Shire NJ, Welge JA, Sherman KE. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine. 2006;24:272-279.
    • (2006) Vaccine , vol.24 , pp. 272-279
    • Shire, N.J.1    Welge, J.A.2    Sherman, K.E.3
  • 13
    • 12844269826 scopus 로고    scopus 로고
    • Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects
    • Wallace MR, Brandt CJ, Earhart KC, et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. Clin Infect Dis. 2004;39:1207-1213.
    • (2004) Clin Infect Dis , vol.39 , pp. 1207-1213
    • Wallace, M.R.1    Brandt, C.J.2    Earhart, K.C.3
  • 14
    • 0030219524 scopus 로고    scopus 로고
    • Hepatitis A vaccine responses in HIV-positive persons with haemophilia
    • Tilzey AJ, Palmer SJ, Harrington C, et al. Hepatitis A vaccine responses in HIV-positive persons with haemophilia. Vaccine. 1996;14:1039-1041.
    • (1996) Vaccine , vol.14 , pp. 1039-1041
    • Tilzey, A.J.1    Palmer, S.J.2    Harrington, C.3
  • 15
    • 0028059681 scopus 로고
    • Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients
    • Santagostino E, Gringeri A, Rocino A, et al. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemost. 1994;72:508-510.
    • (1994) Thromb Haemost , vol.72 , pp. 508-510
    • Santagostino, E.1    Gringeri, A.2    Rocino, A.3
  • 16
    • 0028343370 scopus 로고
    • Influence of smoking on immunological responses to hepatitis B vaccine
    • Winter AP, Follett EA, Mclntyre J, et al. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine. 1994; 12: 771-772.
    • (1994) Vaccine , vol.12 , pp. 771-772
    • Winter, A.P.1    Follett, E.A.2    Mclntyre, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.